Agilent Technologies Financial Ratios

Agilent Technologies Inc -- USA Stock  

USD 71.23  0.5  0.7%

Use fundamental data analysis to double-check all available reported financial drivers of Agilent Technologies Inc to find out if markets are presently mispricing the company. We found thirty-six available fundamental indicators for Agilent Technologies Inc which can be compared to its rivals. To make sure the equity is not overpriced, please confirm all Agilent Technologies Inc fundamentals including its Shares Outstanding, Price to Book, EBITDA, as well as the relationship between Shares Owned by Institutions and Revenue . Given that Agilent Technologies Inc has Price to Earning of 34.16 times, we suggest you validate Agilent Technologies Inc prevailing market performance to make sure the company can sustain itself down the road.Use Agilent Technologies to protect against small markets fluctuations. The stock experiences moderate downward daily trend and can be a good diversifier. Check odds of Agilent Technologies to be traded at $69.81 in 30 days

Agilent Technologies Inc Valuation Over Time

Enterprise Value

Agilent Technologies Company Summary

Agilent Technologies competes with Sensata Technologies, FLIR Systems, AMETEK, and IDEX CP. Its Life Sciences and Applied Markets segment offers liquid chromatography systems and components liquid chromatography mass spectrometry systems gas chromatography systems and components gas chromatography mass spectrometry systems inductively coupled plasma mass spectrometry instruments atomic absorption instruments microwave plasmaatomic emission spectrometry instruments inductively coupled plasma optical emission spectrometry instruments laboratory software and informatics systems laboratory automation and robotic systems dissolution testing vacuum pumps and measurement technologies. Agilent Technologies Incs Diagnostics and Genomics segment offer reagents, instruments, software, and consumables arrays for DNA mutation detection, genotyping, gene copy number determination, identification of gene rearrangements, DNA methylation profiling, and gene expression profiling, as well as sequencing target enrichment services and equipment focused on production of synthesized oligonucleotides for use as active pharmaceutical ingredients. Its Agilent CrossLab segment offers GC and LC columns, sample preparation products, custom chemistries, and various laboratory instrument supplies and startup, operational, training, and compliance support, as well as asset management and consultation services. Agilent Technologies Inc markets and sells its solutions through direct sales, electronic commerce, resellers, manufacturers representatives, and distributors. Agilent Technologies, Inc. was founded in 1999 and is headquartered in Santa Clara, California.

Agilent Technologies Retained Earnings vs Debt to Equity

Agilent Technologies Inc is rated third in retained earnings category among related companies. It is rated fifth in debt to equity category among related companies . The ratio of Retained Earnings to Debt to Equity for Agilent Technologies Inc is about  146,722,892 

Agilent Technologies Inc Systematic Risk

Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Beta measures systematic risk based on how returns on Agilent Technologies Inc correlated with the market. If Beta is less then 0 Agilent Technologies generally moves in the opposite direction as compared to the market. If Agilent Technologies Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Agilent Technologies Inc is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Agilent Technologies is generally in the same direction as the market. If Beta > 1 Agilent Technologies moves generally in the same direction as, but more than the movement of the benchmark. View also all equity analysis or get more info about beta statistic functions indicator.
< 8% 

Chance of Financial Distress

Agilent Technologies Inc has less than 8 (%) percent chance of experiencing financial distress in the next 2 years of operations. More Info

Growth

Agilent Technologies Growth Changes

EPS Diluted Growth

EPS Growth

NCFO Growth

Compare

Compare Agilent Technologies To Peers
Michael McMullen CEO and President Director and Member of Executive Committee
James Cullen Independent Non-Executive Chairman of the Board
More Executives

Opportunity Range

January 17, 2018 Opportunity Range